The study aims to evaluate the effectiveness of lebrikizumab in patients with moderate-to-severe atopic dermatitis who have had multiple prior therapies.
Real-world case series analysis
Assessment of patient outcomes after lebrikizumab treatment
Review of prior treatment history
Positive patient outcomes observed after lebrikizumab administration
Improvement in dermatitis symptoms noted
Evidence suggests potential benefits for patients with limited options
Abstract
The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.